药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Rolitetracycline
Eluxadoline
The serum concentration of Eluxadoline can be increased when it is combined with Dabrafenib.
Rolitetracycline
Trametinib
The risk or severity of adverse effects can be increased when Trametinib is combined with Dabrafenib.
Rolitetracycline
S,R-Warfarin alcohol
The metabolism of S,R-Warfarin alcohol can be increased when combined with Dabrafenib.
Rolitetracycline
R,S-Warfarin alcohol
The metabolism of R,S-Warfarin alcohol can be increased when combined with Dabrafenib.
Rolitetracycline
Perampanel
The metabolism of Perampanel can be increased when combined with Dabrafenib.
Rolitetracycline
Asenapine
Asenapine can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Relebactam
The excretion of Relebactam can be decreased when combined with Dabrafenib.
Rolitetracycline
Edaravone
The excretion of Edaravone can be decreased when combined with Dabrafenib.
Rolitetracycline
Silibinin
The excretion of Silibinin can be decreased when combined with Dabrafenib.
Rolitetracycline
Avibactam
The excretion of Avibactam can be decreased when combined with Dabrafenib.
Rolitetracycline
Cefaloridine
The excretion of Cefaloridine can be decreased when combined with Dabrafenib.
Rolitetracycline
Daclatasvir
The metabolism of Daclatasvir can be increased when combined with Dabrafenib.
Rolitetracycline
Metreleptin
The metabolism of Dabrafenib can be increased when combined with Metreleptin.
Rolitetracycline
Sodium zirconium cyclosilicate
Sodium zirconium cyclosilicate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Salvianolic acid A
Salvianolic acid A can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Aluminium phosphate
Aluminium phosphate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Calcium silicate
Calcium silicate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Niperotidine
Niperotidine can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Aloglutamol
Aloglutamol can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rolitetracycline
Aluminium glycinate
Aluminium glycinate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.